About DSIP - Delta Sleep Inducing Compound Peptide

DSIP (Delta Sleep-Inducing Peptide) is a nine-amino-acid neuropeptide. It was first isolated in 1977 by Swiss researchers Schoenenberger and Monnier. It is named for its apparent ability to promote delta (slow-wave) sleep in research subjects. DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring 9-amino acid neuropeptide first isolated in 1977 from rabbit cerebral blood during slow-wave sleep. Unlike conventional sleeping pills that act as central nervous system sedatives, research shows DSIP functions primarily as a neuroregulatory adaptogen.

WHAT THE RESEARCH SHOWS
* Promotes Delta (Slow-Wave) Sleep: * DSIP's primary claim to fame is its ability to induce and lengthen slow-wave (delta) sleep, the deepest stage of non-REM sleep where physical recovery, tissue repair, and growth hormone pulses peak.
* Research shows it normalizes disrupted sleep architecture rather than forcing sleep. It does not suppress REM sleep or produce the groggy "hangover" effect typical of benzodiazepines or Z-drugs.
* HPA Axis Regulation & Cortisol Reduction:
* Multiple studies show DSIP modulates the hypothalamic-pituitary-adrenal (HPA) axis. During chronic stress, it significantly suppresses elevated nighttime cortisol and ACTH levels, helping shift the nervous system out of a constant "fight-or-flight" state.
* Withdrawal & Pain Modulation: * In European human clinical trials during the 1980s, DSIP was evaluated for treating acute alcohol and opiate withdrawal. Studies found it significantly reduced physical withdrawal symptoms, autonomic hyperactivity, and craving-related anxiety by modulating central GABA and endogenous opioid pathways.
* Antioxidant & Neuroprotective Actions:
* Preclinical research shows DSIP reduces oxidative stress and lipid peroxidation in brain tissue under acute physiological or environmental stress, acting as a cellular protectant in the central nervous system. * The "Bell-Shaped" Response:
* Research consistently highlights a bell-shaped dose-response curve: higher doses do not equal better results and can actually be less effective. Typical research doses stay low around 100mcg to 250mcg. The Bottom Line: DSIP is not an immediate "knockout" drug. Research shows it is best understood as a circadian and stress regulator that restores the body's natural sleep-wake rhythm, lowers nighttime stress hormones, and optimizes deep, restorative recovery.

Lyophilised powder